Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Relay Therapeutics Q1 EPS $(0.46) Beats $(0.48) Estimate, Sales $7.68M Beat $10.00K Estimate

Author: Benzinga Newsdesk | May 05, 2025 03:16pm
Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.48) by 4.17 percent. This is a 25.81 percent increase over losses of $(0.62) per share from the same period last year. The company reported quarterly sales of $7.68 million which beat the analyst consensus estimate of $10.00 thousand by 76.69K percent. This is a 23.26 percent decrease over sales of $10.01 million the same period last year.

Posted In: RLAY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist